TP53 and cancer: Consistently, an analysis of human breast tumors without TP53 mutations revealed that some of these tumors exhibited transcriptional profiles, pathway and deregulation patterns similar to those of cancers harboring mutant TP53. Patients with this subset of tumors had survival rates comparable to those of patients with mutant TP53 tumors [22].